Arcutis Biotherapeutics, Inc. (ARQT) Ownership

NASDAQ Currency in USD Disclaimer

$14.99

north_east $0.02 (0.13%)
Day's range
$14.43
Day's range
$15.1

Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JENNISON ASSOCIATES LLC 11/08/2024 11.66 M $108.47 M   0.79% 9.38%
RUBRIC CAPITAL MANAGEMENT LP 11/13/2024 10.97 M $101.99 M   11.71% 8.82%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2024 10.72 M $99.71 M   7.17% 8.63%
BLACKROCK FUNDING, INC. /DE 11/13/2024 9.03 M $83.97 M   100.00% 7.26%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/15/2024 8.79 M $81.70 M   0.00% 7.07%
VANGUARD GROUP INC 11/13/2024 6.96 M $64.75 M   13.32% 5.60%
POLAR CAPITAL HOLDINGS PLC 11/14/2024 6.88 M $64.02 M   0.08% 5.54%
STATE STREET CORP 11/14/2024 5.64 M $52.47 M   9.87% 4.54%
FRANKLIN RESOURCES INC 11/27/2024 4.25 M $41.40 M   -4.23% 3.42%
MORGAN STANLEY 11/14/2024 3.78 M $35.17 M   -4.82% 3.04%
GILDER GAGNON HOWE & CO LLC 11/14/2024 3.55 M $33.05 M   -1.73% 2.86%
CITADEL ADVISORS LLC 11/14/2024 3.03 M $28.19 M   3.36% 2.44%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 2.47 M $22.98 M   2.02% 1.99%
ENSIGN PEAK ADVISORS, INC 11/14/2024 2.42 M $22.48 M   13.27% 1.94%
CORMORANT ASSET MANAGEMENT, LP 11/14/2024 2.33 M $21.62 M   -7.92% 1.87%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 11/13/2024 2.12 M $19.72 M   3.89% 1.71%
STEMPOINT CAPITAL LP 11/13/2024 1.78 M $16.54 M   84.21% 1.43%
D. E. SHAW & CO., INC. 11/14/2024 1.75 M $16.23 M   73.22% 1.40%
GW&K INVESTMENT MANAGEMENT, LLC 11/07/2024 1.59 M $14.82 M   -4.46% 1.28%
GOLDMAN SACHS GROUP INC 11/14/2024 1.59 M $14.79 M   96.93% 1.28%
J. GOLDMAN & CO LP 11/14/2024 1.49 M $13.88 M   13.78% 1.20%
AMERICAN CENTURY COMPANIES INC 11/12/2024 1.46 M $13.62 M   18.89% 1.18%
CANDRIAM S.C.A. 11/13/2024 1.43 M $13.27 M   9.10% 1.15%
PERCEPTIVE ADVISORS LLC 11/14/2024 1.36 M $12.63 M   -12.83% 1.09%
JPMORGAN CHASE & CO 11/08/2024 1.30 M $12.06 M   0.92% 1.04%
BANK OF AMERICA CORP /DE/ 11/14/2024 1.18 M $10.94 M   107.35% 0.95%
TEJARA CAPITAL LTD 11/13/2024 1.17 M $10.84 M   -13.27% 0.94%
MILLENNIUM MANAGEMENT LLC 11/14/2024 1.15 M $10.67 M   123.81% 0.92%
INVESCO LTD. 11/12/2024 938,484 $8.73 M   0.09% 0.76%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 859,846 $8.00 M   1.00% 0.69%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 807,650 $7.51 M   9.88% 0.65%
LAZARD ASSET MANAGEMENT LLC 11/14/2024 803,204 $7.47 M   123.11% 0.65%
EVERSEPT PARTNERS, LP 11/14/2024 693,263 $6.45 M   -17.26% 0.56%
ABRDN PLC 10/25/2024 482,074 $4.48 M   223.81% 0.39%
FISHMAN JAY A LTD/MI 10/30/2024 418,000 $3.89 M   20.60% 0.34%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/12/2024 323,701 $3.01 M   -70.93% 0.26%
PDT PARTNERS, LLC 11/14/2024 319,715 $2.97 M   0.00% 0.26%
TWO SEAS CAPITAL LP 11/14/2024 312,122 $2.90 M   -59.05% 0.25%
BANK OF NEW YORK MELLON CORP 11/12/2024 311,059 $2.89 M   -20.28% 0.25%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 276,818 $2.57 M   6.68% 0.22%
BARCLAYS PLC 11/19/2024 253,392 $2.36 M   148.15% 0.20%
AQR CAPITAL MANAGEMENT LLC 11/14/2024 252,151 $2.35 M   -2.02% 0.20%
STEMPOINT CAPITAL LP 11/13/2024 250,000 $12,500   -50.00% 0.20%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2024 244,386 $2.27 M   100.00% 0.20%
GSA CAPITAL PARTNERS LLP 11/05/2024 237,174 $2.21 M   730.01% 0.19%
AMI ASSET MANAGEMENT CORP 10/25/2024 223,681 $2.08 M   36.23% 0.18%
UBS GROUP AG 11/14/2024 220,194 $2.05 M   -28.87% 0.18%
SWISS NATIONAL BANK 11/07/2024 203,600 $1.89 M   0.00% 0.16%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 192,099 $1.79 M   100.00% 0.15%
TWO SIGMA ADVISERS, LP 11/14/2024 182,800 $1.70 M   -62.59% 0.15%

Arcutis Biotherapeutics, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of ARQT shares?

During the previous two years, 220 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:

JENNISON ASSOCIATES LLC: 11.66 M

Rubric Capital Management LP: 10.97 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 10.72 M

BlackRock Funding, Inc. /DE: 9.03 M

Frazier Life Sciences Management, L.P.: 8.79 M

VANGUARD GROUP INC: 6.96 M

What percentage of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors?

103.37% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.

How much institutional buying is happening at ARQT ?

Institutional investors have bought a total of 136.14 M shares in the last 24 months. This purchase volume represents approximately $2.04 B in transactions.